Medication review is an intervention with the potential to reduce drug-related problems (DRPs) in the elderly. This study aimed to determine the effect of pharmacists’ medication reviews on geriatric patients. This study accessed two online databases, MEDLINE Complete and Scopus, and examined all studies published in English between 2019 and 2023, except for reviews. The studies included (1) participants over 65 years of age and (2) medication reviews conducted by pharmacists. The titles, abstracts, and full texts were reviewed for data extraction to determine whether the studies satisfied the inclusion and exclusion criteria. Forty-four of the initial 709 articles were included in this study. The articles included discussions on the incidence rates of DRPs and potentially inappropriate medications (PIMs) (n=21), hospitalization (n=14), medication adherence (n=9), quality of life (QoL) (n=8), and falls (n=7). Pharmacist medication reviews were associated with a reduced incidence of DRPs and PIMs, and improved adherence to medications. Patients’ overall QoL is also increasing. However, pharmacist medication reviews were not strongly associated with decreased hospitalization or falls. A pharmacist’s medication review may be a feasible intervention for reducing the incidence rates of DRPs and PIMs, regardless of whether it is performed as a sole intervention or supplemented with other interventions. The intervention was also effective in increasing medication adherence and QoL.
Citations
Citations to this article as recorded by
Quality of prescribing and health-related quality of life in older adults: a narrative review with a special focus on patients with atrial fibrillation and multimorbidity Cheima Amrouch, Deirdre A. Lane, Amaia Calderón-Larrañaga, Mirko Petrovic, Delphine De Smedt European Geriatric Medicine.2025; 16(4): 1137. CrossRef
Effectiveness of Pharmacist Interventions in Improving Medication Use in Hospitalised Older Patients Diagnosed With Cardiovascular Diseases: INFAR Before‐and‐After Study Romana Santos Gama, Luiz Carlos Passos, Welma Wildes Amorim, Renato Morais Souza, Marcio Galvão Oliveira Journal of Evaluation in Clinical Practice.2025;[Epub] CrossRef
A Systematic Review of Long-Term Use of Proton Pump Inhibitors (PPIs) in Older Adults on Polypharmacy: Do PPIs Deplete Nutrients? Muhammad Salman Shahid, Nouman Ahmed, Zeeshan Kamal, Laibah Nathaniel, Bhavna Singla, Shivam Singla, Sunita Kumawat, Munaza Batool, Osatohanmwen Ekomwereren, Nabila N Anika, Muhammad Sahil Cureus.2025;[Epub] CrossRef
Erratum: The Impact of Pharmacist Medication Reviews on Geriatric Patients: A Scoping Review Nor Liana Che Yaacob, Mathumalar Loganathan, Nur Azwa Hisham, Habibah Kamaruzzaman, Khairil Anuar Md Isa, Mohamed Izham Mohamed Ibrahim, Kwok-Wen Ng Korean Journal of Family Medicine.2024; 45(4): 235. CrossRef
Application of the Statin-Associated Muscle Symptoms-Clinical Index to a Cohort of Patients with Type 2 Diabetes Mellitus Undergoing Phlebotomy at an Endocrinology Clinic Nor Humaira Mohd Tajudin, Mathumalar Loganathan Fahrni, Rohana Abdul Ghani, Mohd Hazriq Awang, Hitesh Chopra, Ali Saleh Alkhoshaiban Journal of Pharmacology and Pharmacotherapeutics.2024; 15(4): 389. CrossRef
Contribución de los Farmacéuticos Comunitarios en la detección y notificación de reacciones adversas en Andalucía Miguel Romero Pérez, Manuel Sánchez Polo, José Alberto Ayala Ortiz, Blanca Contreras Aguilar, María José Zarzuelo-Romero Ars Pharmaceutica (Internet).2024; 66(1): 25. CrossRef
Pharmacovigilance is used to detect, assess, understand, and prevent the adverse effects of medications. The need for safety monitoring has evolved around unfortunate incidents in history, with deaths caused by anesthesia and congenital malformations from thalidomide use. Reports from adverse drug reactions (ADRs) are stored in a global database and can be used to evaluate the associations between various medications and associated ADRs. Clinicians play an important role in the recognition and reporting of ADRs to national pharmacovigilance centers (NPCs). The purpose of NPCs is to make the clinicians understand their functions, including the monitoring, investigation, and assessment of ADR reports, along with periodical benefit-risk assessments of medications via multiple sources. A case study on NPCs and the types of safety issues evaluated by them are provided to illustrate their role in medicine safety surveillance. ADR monitoring was also combined with vaccine safety surveillance approaches. Overall, this study will provide insights to clinicians on the importance of pharmacovigilance in maintaining patient safety with the proper use of medications.
Citations
Citations to this article as recorded by
Teaching approaches to delivering pharmacy law content to pre-registration pharmacy students: a global systematic scoping review Helen Ibrahim, Bandana Saini, Jessica Pace Currents in Pharmacy Teaching and Learning.2026; 18(1): 102507. CrossRef
Analysis of literature-derived duplicate records in the FDA Adverse Event Reporting System (FAERS) database Weiru Han, Robert Morris, Kun Bu, Tianrui Zhu, Hong Huang, Feng Cheng Canadian Journal of Physiology and Pharmacology.2025; 103(2): 56. CrossRef
Leveraging Natural Language Processing and Machine Learning Methods for Adverse Drug Event Detection in Electronic Health/Medical Records: A Scoping Review Su Golder, Dongfang Xu, Karen O’Connor, Yunwen Wang, Mahak Batra, Graciela Gonzalez Hernandez Drug Safety.2025; 48(4): 321. CrossRef
Patient Experience Regarding Medication-Related Information Received in a Rural Private Polyclinic Setting in Vietnam Quang Loc Duyen Vo, Minh Trung Nguyen, Thi Ngoc Yen Dang, Thi Hong Dung Quach, Huynh Kim Ngoc Truong, Rebecca Susan Dewey, Thi Thu Tran, Van De Tran Journal of Patient Experience.2025;[Epub] CrossRef
Interações Fármaco-fármaco em Prescrições de Pacientes em Unidade de Terapia Intensiva Adulto em Hospital Público de Montes Claros Anna Lívia Lima, Kelly Cristiane Lopes, Esther Alves Marinho , Flávio Júnior Figueredo , Cecília Paiva Duarte , Viviane de Oliveira Vasconcelos, Izabella Mendes Lima , Thiago Santos Monção, Guilherme Henrique Azevedo dos Reis , Yves André Rodrigues Gomes Revista de Gestão e Secretariado.2025; 16(2): e4715. CrossRef
A critical comparison of pharmacovigilance reporting forms in six countries with the WHO-UMC recommendations (form of the form) Saurav Misra, Manmeet Kaur, Jayant Kumar Kairi Journal of Basic and Clinical Physiology and Pharmacology.2025; 36(4): 285. CrossRef
Glucocorticoid withdrawal syndrome: Disproportionality analysis of cases using VigiBase data Lütfi Mangal, Burcu Eda Arda, Hande Sipahi DARU Journal of Pharmaceutical Sciences.2025;[Epub] CrossRef
Enhancing Public Health with Pharmacovigilance: Tools, Strategies, and Impacts Sujitha Pandian, Yashvanthan Vinjmur Ragavan, Angeline Grace Pandian, Ajith Kumar Kumaraguru, Kiran Kartheep Subramanian Biomedical and Pharmacology Journal.2025; 18(2): 1147. CrossRef
Artificial Intelligence in Pharmacovigilance Dinesh Kumar, Amandeep Kaur, Shruti, Davender Kaur Current Computer Science.2025;[Epub] CrossRef
Excipients in pharmaceuticals: mechanisms of hypersensitivity and the role of global pharmacovigilance Ruba Malkawi, Lora Altahrawi Saudi Pharmaceutical Journal.2025;[Epub] CrossRef
Exploring pharmacovigilance awareness and attitudes among healthcare practitioners in Iraq: insights from a survey-based study Hussein Abdulmohsin Dabis, Ali Talib Hameed Jurnal Ners.2025; 20(1): 3. CrossRef
A PHARMACOVIGILANCE STUDY TO ASSESS THE EFFECT OF ADVERSE DRUG REACTION ON PEDIATRIC HEALTH ARULRAJA S, THILIP KUMAR GNANADURAI, SUBBULAKSHMI RAMASAMY Asian Journal of Pharmaceutical and Clinical Research.2025; : 87. CrossRef
Association between DPP4 inhibitor use and risk of skin cancer in type 2 diabetes: A real-world cohort study Zaryab Alam, Kevin T. Nguyen, Hamza Malick, Kyle C. Lauck, Stanislav N. Tolkachjov Journal of the American Academy of Dermatology.2025;[Epub] CrossRef
Safety of COVID-19 Vaccination During Pregnancy and Lactation: A VigiBase Analysis Dayeon Kang, Ahhyung Choi, Suneun Park, Seung-Ah Choe, Ju-Young Shin Journal of Korean Medical Science.2024;[Epub] CrossRef
Revolutionizing drug discovery: The impact of artificial intelligence on advancements in pharmacology and the pharmaceutical industry Seema Yadav, Abhishek Singh, Rishika Singhal, Jagat Pal Yadav Intelligent Pharmacy.2024; 2(3): 367. CrossRef
Drug Repurposing Using FDA Adverse Event Reporting System (FAERS)
Database Robert Morris, Rahinatu Ali, Feng Cheng Current Drug Targets.2024; 25(7): 454. CrossRef
Drug-Related Glomerular Phenotypes: A Global Pharmacovigilance Perspective Alexandre Baptista, Ana M. Macedo, Ana Marreiros, André Coelho, Mark A. Perazella Journal of Clinical Medicine.2024; 13(16): 4869. CrossRef
Postmarketing Surveillance: Review of Open Sources of Drug Safety Data E. V. Shubnikova Safety and Risk of Pharmacotherapy.2024; 12(3): 309. CrossRef
Exploring the community pharmacist’s knowledge, attitude, and practices regarding adverse drug reactions and its reporting in the United Arab Emirates: a survey-based cross-sectional study Javedh Shareef, Sathvik Belagodu Sridhar, Mullaicharam Bhupathyraaj, Atiqulla Shariff, Sabin Thomas Therapeutic Advances in Drug Safety.2024;[Epub] CrossRef
Pharmacovigilance: A Comprehensive Review of Drug Safety Monitoring Practices Aniket Anil Pawar, Aftab Imtiyaz Patel, Suhani Balu Jadhav, Harshavardhan T. Suryawanshi, Suhani Balu Jadhav International Journal of Advanced Research in Science, Communication and Technology.2024; : 314. CrossRef
Explicit potentially inappropriate medications criteria for older population in Asian countries: A systematic review Chee Tao Chang, Siew Li Teoh, Philip Rajan, Shaun Wen Huey Lee Research in Social and Administrative Pharmacy.2023; 19(8): 1146. CrossRef
A Real-World Data Driven Pharmacovigilance Investigation on Drug-Induced Arrhythmia Using KAERS DB, a Korean Nationwide Adverse Drug Reporting System Chaerin Go, Semi Kim, Yujin Kim, Yongjun Sunwoo, Sae Hyun Eom, Jiseong Yun, Sooyoung Shin, Yeo Jin Choi Pharmaceuticals.2023; 16(11): 1612. CrossRef
First
Prev
